SF3B1 and B-cell chronic lymphocytic leukemia: We found SF3B1 mutation frequency was significantly higher in subjects with advanced, fludarabine-resistant CLL consistent with the notion detection of these mutations result from expansion of a sub-clone of CLL cells and are acquired during disease progression [15, 16].